Kentanix Supra International Tbk. vs Merck Tbk. — how do they compare? Kentanix Supra International Tbk. trades at Rp280 (market cap 594.32B, 17K 24h volume), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume). The key difference: Merck Tbk. is far larger — about 2.9× Kentanix Supra International Tbk.'s market cap, and Merck Tbk. is more actively traded (37.6K versus 17K). Which is the better fit depends on your goals.
| KSIX | MERK | |
|---|---|---|
Market Cap | 594.32B | 1.7T |
Volume | 17K | 37.6K |
Lot | 170 | 376 |
Turnover | 4.73M | 144.47M |
Average Price | 278.14 | 3,842.23 |
Value | 4.73M | 144.47M |
Indicative Equilibrium Price | 278 | 3,840 |
Indicative Equilibrium Volume | 500 | 7 |
Trailing returns across standard periods
Latest headlines on both assets
PT Kentanix Supra International Tbk (the Company) was established based on Notarial Deed No. 41 dated October 27, 1980 of Samsul Hadi, S.H., as amended by Deed No. 25 dated April 8, 1981 and Deed No. 10 dated October 9, 1981 of the same Notary. The Company commenced its commercial operations in 1985. PT Badra Arta, a company incorporated in Indonesia, is the parent entity of the Company.
Read more on KSIX →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →